Form 4: Anixa Biosciences CEO Amit Kumar Acquires 25,000 Shares of Common Stock
SEC Form 4 Filing
Anixa Biosciences CEO Amit Kumar purchased 25,000 shares of common stock at $2.41 per share on June 7, 2024.
Summary
- On June 7, 2024, Amit Kumar, the CEO of Anixa Biosciences Inc., acquired 25,000 shares of common stock.
- The purchase price was $2.41 per share.
- Following the transaction, Kumar directly owns 516,925 shares of Anixa Biosciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, indicating that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Amit Kumar acquired 25,000 shares of Anixa Biosciences common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.